Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             188 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A Clinical Diagnostic Study: Fibulin-2 is a Novel Promising Biomarker for Predicting Infection Li, Shidan

3 p. 1057-1073
artikel
2 A Comparison of Current Guidelines of Five International Societies on Clostridium difficile Infection Management Fehér, Csaba
2016
3 p. 207-230
artikel
3 A Comprehensive Review of Meningococcal Disease Burden in India Dutta, Ashok Kumar

3 p. 537-559
artikel
4 Agreement Between Two Procalcitonin Assays in Hospitalized Children Katz, Sophie E.
2019
3 p. 463-468
artikel
5 A Letter to the Editor Regarding ‘Identifying Gaps in the Corticosteroid Treatment of COVID-19: We Need More Studies’ Yildirim, Fatma

3 p. 1013-1016
artikel
6 Amoebic Liver Abscess: Potential Application of New Diagnostic Techniques for an Old Pathogen Portunato, Federica

3 p. 625-632
artikel
7 A Nonlinear Time-Series Analysis to Identify the Thresholds in Relationships Between Antimicrobial Consumption and Resistance in a Chinese Tertiary Hospital Chen, Shixing

3 p. 1019-1032
artikel
8 A Novel Prediction Model of COVID-19 Progression: A Retrospective Cohort Study Xu, Wei

3 p. 1491-1504
artikel
9 Antibiotic Discontinuation Rates Associated with Positive Respiratory Viral Panel and Low Procalcitonin Results in Proven or Suspected Respiratory Infections Timbrook, Tristan
2015
3 p. 297-306
artikel
10 A Population-Based Study on the Incidence, Risk Factors, and Outcome of Salmonella Bloodstream Infections in South Sweden 2012–2022 Björklund, L.

3 p. 501-519
artikel
11 A Prospective Study of Etiological Agents Among Febrile Patients in Sierra Leone Wang, Han

3 p. 1645-1664
artikel
12 A Response to: Letter to the Editor Regarding Combination of Tocilizumab and Steroids to Improve Mortality in Patients with Severe COVID-19 Infection: A Spanish, Multicenter, Cohort Ruiz-Antorán, Belén

3 p. 1811-1813
artikel
13 A Response to: Letter to the Editor Regarding “Cost-Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Versus Lower-Valent Alternatives in Filipino Infants” Perdrizet, Johnna

3 p. 1301-1303
artikel
14 A Review of HIV Pre-Exposure Prophylaxis: The Female Perspective Bailey, Jennifer L.
2017
3 p. 363-382
artikel
15 A Survey of Patients’ Perspectives on Outpatient HIV Care in the Netherlands Engelhard, Esther A. N.
2017
3 p. 443-452
artikel
16 A Systematic Review of the Clinical Utility of Cycle Threshold Values in the Context of COVID-19 Rao, Sonia N.

3 p. 573-586
artikel
17 Bacteriophage Proteome: Insights and Potentials of an Alternate to Antibiotics Aslam, Bilal

3 p. 1171-1193
artikel
18 Baseline Characteristics and Outcomes Among Patients with Complicated Skin and Soft Tissue Infections Admitted to the Intensive Care Unit: Analysis of the Phase 3 COVERS Randomized Trial of Ceftaroline Fosamil Versus Vancomycin Plus Aztreonam Sánchez-García, Miguel

3 p. 609-623
artikel
19 Bezlotoxumab for Preventing Recurrent Clostridioides difficile Infection: A Narrative Review from Pathophysiology to Clinical Studies Giacobbe, Daniele Roberto

3 p. 481-494
artikel
20 BioFire® FilmArray® Pneumonia Panel for Severe Lower Respiratory Tract Infections: Subgroup Analysis of a Randomized Clinical Trial Kyriazopoulou, Evdoxia

3 p. 1437-1449
artikel
21 Bordetella pertussis in School-Age Children, Adolescents, and Adults: A Systematic Review of Epidemiology, Burden, and Mortality in Africa Macina, Denis

3 p. 1097-1113
artikel
22 Bordetella pertussis in School-Age Children, Adolescents, and Adults: A Systematic Review of Epidemiology, Burden, and Mortality in Asia Macina, Denis

3 p. 1115-1140
artikel
23 Candida auris Candidemia in Critically Ill, Colonized Patients: Cumulative Incidence and Risk Factors Briano, Federica

3 p. 1149-1160
artikel
24 Causal Associations Between Tobacco, Alcohol Use and Risk of Infectious Diseases: A Mendelian Randomization Study Zhu, Hongxiang

3 p. 965-977
artikel
25 Cefiderocol, a Siderophore Cephalosporin, as a Treatment Option for Infections Caused by Carbapenem-Resistant Enterobacterales Kaye, Keith S.

3 p. 777-806
artikel
26 Ceftazidime-Avibactam in Combination with In Vitro Non-susceptible Antimicrobials Versus Ceftazidime-Avibactam in Monotherapy in Critically Ill Patients with Carbapenem-Resistant Klebsiella Pneumoniae Infection: A Retrospective Cohort Study Zheng, Guanhao

3 p. 1699-1713
artikel
27 Challenges to Differentiate Hepatitis C Genotype 1 and 6: Results from A Field-Study in Cambodia De Weggheleire, Anja

3 p. 657-667
artikel
28 Clinical and Economic Burden of Hepatic and Extrahepatic Complications from Chronic Hepatitis C: A Retrospective Analysis of German Sickness Fund Data Kraus, Michael R.
2018
3 p. 327-338
artikel
29 Clinical and Economic Impact of a Potential Switch from 13-Valent to 10-Valent Pneumococcal Conjugate Infant Vaccination in Canada Wilson, Michele
2018
3 p. 353-371
artikel
30 Clinical and Microbiological Characterization of Bloodstream Infections Caused by Mycoplasma hominis: An Overlooked Pathogen Zeng, Tong

3 p. 1003-1017
artikel
31 Clinical and Molecular Epidemiology of Extended-Spectrum Beta-Lactamase-Producing Escherichia Coli Infections in Metro Detroit: Early Dominance of the ST-131 Clone Mills, John P.

3 p. 683-690
artikel
32 Clinical Characteristics Associated with Bacterial Bloodstream Coinfection in COVID-19 Rebold, Nicholas

3 p. 1281-1296
artikel
33 Clinical Characteristics of Uncomplicated Acute Pyelonephritis Caused by Escherichia coli and Klebsiella pneumoniae Hyun, Miri

3 p. 581-595
artikel
34 Clinical Features of Bloodstream Infections Associated with Peripheral Versus Central Venous Catheters Tatsuno, Keita
2019
3 p. 343-352
artikel
35 Clinical Presentation and Outcome of COVID-19 in a Latin American Versus Spanish Population: Matched Case-Control Study Alonso, Rodrigo

3 p. 1243-1251
artikel
36 Clinical Relevance of Xpert MRSA/SA in Guiding Therapeutic Decisions for Staphylococcal Infections: A Diagnostic Test Accuracy Analysis Ojha, Suvash Chandra

3 p. 1205-1227
artikel
37 Clostridium difficile Infection in Special High-Risk Populations Cózar-Llistó, Alberto
2016
3 p. 253-269
artikel
38 4CMenB Vaccination to Prevent Meningococcal B Disease in Vietnam: Expert Review and Opinion Nguyen, Phung Nguyen The

3 p. 423-437
artikel
39 Combined RT-PCR and Host Response Point-of-Care Testing in Patients Hospitalised with Suspected COVID-19: A Prospective Diagnostic Accuracy Study Brendish, Nathan J.

3 p. 1267-1280
artikel
40 Communicating Benefits from Vaccines Beyond Preventing Infectious Diseases Chevalier-Cottin, Emma-Pascale

3 p. 467-480
artikel
41 Comparative Efficacy and Safety of Vancomycin, Linezolid, Tedizolid, and Daptomycin in Treating Patients with Suspected or Proven Complicated Skin and Soft Tissue Infections: An Updated Network Meta-Analysis Feng, Jingjuan

3 p. 1531-1547
artikel
42 Comparison of Virological Efficacy of DTG/ABC/3TG and B/F/TAF Regimens and Discontinuation Patterns in Persons Living with Advanced HIV in the Era of Rapid ART: A Retrospective Multicenter Cohort Study Lee, Chun-Yuan

3 p. 843-861
artikel
43 Comparisons of Serologic Responses of Early Syphilis to Treatment with a Single-Dose Benzathine Penicillin G Between HIV-Positive and HIV-Negative Patients Lin, Kuan-Yin

3 p. 1287-1298
artikel
44 Contemporary Trends of Reported Sepsis Among Maternal Decedents in Texas: A Population-Based Study Oud, Lavi
2015
3 p. 321-335
artikel
45 Contribution of Penicillin Allergy Labels to Second-Line Broad-Spectrum Antibiotic Prescribing for Pediatric Respiratory Tract Infections Hersh, Adam L.

3 p. 677-681
artikel
46 Correction to: A Dalbavancin Lock Solution Can Reduce Enterococcal Biofilms After Freezing Díaz-Navarro, Marta

3 p. 1305-1310
artikel
47 Correction to: A Systematic Review of the Clinical Utility of Cycle Threshold Values in the Context of COVID-19 Rao, Sonia N.

3 p. 587
artikel
48 Correction to: Comparison of Virological Efficacy of DTG/ABC/3TG and B/F/TAF Regimens and Discontinuation Patterns in Persons Living with Advanced HIV in the Era of Rapid ART: A Retrospective Multicenter Cohort Study Lee, Chun-Yuan

3 p. 863-869
artikel
49 Correction to: Efficacy of Bacillus Calmette–Guérin (BCG) Vaccination in Reducing the Incidence and Severity of COVID-19 in High-Risk Population (BRIC): a Phase III, Multi-centre, Quadruple-Blind Randomised Control Trial Sinha, Sanjeev

3 p. 1017-1018
artikel
50 Correction to: Estimates of the Health and Economic Burden of Pneumococcal Infections Attributable to the 15-Valent Pneumococcal Conjugate Vaccine Serotypes in the USA Owusu-Edusei, Kwame

3 p. 1001
artikel
51 Correction to: GMMA Technology for the Development of Safe Vaccines: Meta-Analysis of Individual Patient Data to Assess the Safety Profile of Shigella sonnei 1790GAHB Vaccine in Healthy Adults, with Special Focus on Neutropenia De Ryck, Iris

3 p. 1313
artikel
52 Correction to: Paediatric Recurrent Ear, Nose and Throat Infections and Complications: Can We Do More? Marengo, Ricardo

3 p. 697-700
artikel
53 Correction to: Public Health Impact and Cost-Effectiveness Analysis of Routine Infant 4CMenB Vaccination in Germany to Prevent Serogroup B Invasive Meningococcal Disease Scholz, Stefan

3 p. 1311
artikel
54 Correction to: Vaccine Hesitancy as a Challenge or Vaccine Confidence as an Opportunity for Childhood Immunisation in India Agrawal, Ashish

3 p. 433
artikel
55 Cost-Effectiveness Analysis of the South African Infant National Immunization Program for the Prevention of Pneumococcal Disease Huang, Liping

3 p. 933-950
artikel
56 Cost-Effectiveness of Dolutegravir in HIV-1 Treatment-Naive and Treatment-Experienced Patients in Canada Despiégel, Nicolas
2015
3 p. 337-353
artikel
57 Cost-Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Versus Lower-Valent Alternatives in Filipino Infants Dhere, Rajeev

3 p. 1297-1299
artikel
58 Cost of Illness Analysis of Invasive Meningococcal Disease Caused by Neisseria Meningitidis Serogroup B in the Netherlands—a Holistic Approach Zeevat, Florian

3 p. 481-499
artikel
59 COVID-19: An Alert to Ventilator-Associated Bacterial Pneumonia Póvoa, Helvécio Cardoso Corrêa

3 p. 417-420
artikel
60 COVID-19: Zinc and Angiotensin-Converting Enzyme 2 (ACE2) Deficiencies as Determinants of Risk and Severity of Disease: A Narrative Review Salgo, Miklos P.

3 p. 1215-1225
artikel
61 Cytomegalovirus Glycoprotein Polymorphisms and Increasing Viral Load in Non-Transplant Patients with Hematological Malignancies Undergoing Chemotherapy: A Prospective Observational Study Handous, Imene

3 p. 1549-1566
artikel
62 Cytomegalovirus Infection and the Implications of Drug-Resistant Mutations in Pediatric Allogeneic Hematopoietic Stem Cell Transplant Recipients: A Retrospective Study from a Tertiary Hospital in China Yu, Uet

3 p. 1309-1322
artikel
63 Dalbavancin: A Novel Lipoglycopeptide Antibiotic with Extended Activity Against Gram-Positive Infections Smith, Jordan R.
2015
3 p. 245-258
artikel
64 Dalbavancin Sequential Therapy for Gram-Positive Bloodstream Infection: A Multicenter Observational Study Rebold, Nicholas

3 p. 565-579
artikel
65 Daptomycin for the Treatment of Infective Endocarditis: Results from European Cubicin® Outcomes Registry and Experience (EU-CORE) Guleri, Achyut
2015
3 p. 283-296
artikel
66 Defining the Epidemiology and Burden of Severe Respiratory Syncytial Virus Infection Among Infants and Children in Western Countries Bont, Louis
2016
3 p. 271-298
artikel
67 Defining the Incidence and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Children with Chronic Diseases Manzoni, Paolo
2017
3 p. 383-411
artikel
68 Desirable Characteristics of Hepatitis C Treatment Regimens: A Review of What We Have and What We Need Bidell, Monique R.
2016
3 p. 299-312
artikel
69 Development and Validation of a Clinical Predictive Model for Bacterial Infection in Hepatitis B Virus-Related Acute-on-Chronic Liver Failure Zhang, Zhongwei

3 p. 1347-1361
artikel
70 Different Trends of Distinct Time Points of AIDS Events Following HIV Diagnosis in Various At-risk Populations: A Retrospective Nationwide Cohort Study in Taiwan Lee, Chun-Yuan

3 p. 1715-1732
artikel
71 Direct-Acting Antivirals Remain Cost-Effective Treatments for Chronic Hepatitis C in Australia Despite Changes to the Treated Population and the Availability of Retreatment: The Glecaprevir/Pibrentasvir (Maviret®) Example Warren, Emma

3 p. 549-564
artikel
72 Dynamic Antibody Responses in Patients with Different Severity of COVID-19: A Retrospective Study Lu, Wanrong

3 p. 1379-1390
artikel
73 Dynamic Changes in the Immune Response Correlate with Disease Severity and Outcomes During Infection with SARS-CoV-2 Zheng, Fang

3 p. 1391-1405
artikel
74 Economic Evaluation of Human Rotavirus Vaccine in Thailand Saokaew, Surasak
2019
3 p. 397-415
artikel
75 Effectiveness of a Clinical Pathway for Hepatic Cystic Echinococcosis Surgery in Kashi Prefecture, Northwestern China: A Propensity Score Matching Analysis Ibrahim, Irshat

3 p. 1465-1477
artikel
76 Effectiveness of Favipiravir on Nonsevere, Early-Stage COVID-19 in Japan: A Large Observational Study Using the COVID-19 Registry Japan Tsuzuki, Shinya

3 p. 1075-1087
artikel
77 Effect of Additional Clostridium butyricum on the Intestinal Flora of Chronic Hepatitis B Patients Treated with Entecavir Lu, Yu-Xia

3 p. 1519-1530
artikel
78 Effect of Anti-HBs on Mortality Among Resolved HBV Infection: a Population-Based Prospective Cohort Study Huang, Shuai-Wen

3 p. 871-890
artikel
79 Effect of Renal Impairment on Pharmacokinetics and Safety of Ensitrelvir, a SARS-CoV-2 3CL Protease Inhibitor Katsube, Takayuki

3 p. 597-607
artikel
80 Efficacy and Safety of Tocilizumab Treatment COVID-19 Patients: A Case-Control Study and Meta-Analysis Jiang, Weijun

3 p. 1677-1698
artikel
81 Epidemiologic Trends, Global Shifts in Meningococcal Vaccination Guidelines, and Data Supporting the Use of MenACWY-TT Vaccine: A Review Presa, Jessica
2019
3 p. 307-333
artikel
82 Epidemiology and Incidence of COVID-19-Associated Pulmonary Aspergillosis (CAPA) in a Greek Tertiary Care Academic Reference Hospital Paramythiotou, Elisabeth

3 p. 1779-1792
artikel
83 Epidemiology and Risk Factors for Community-Associated Clostridium difficile Infection: A Narrative Review Bloomfield, Lauren E.
2016
3 p. 231-251
artikel
84 Epidemiology of Respiratory Pathogens Among Children Hospitalized for Pneumonia in Xiamen: A Retrospective Study Sun, Yong-Peng

3 p. 1567-1578
artikel
85 Erratum to: In Vitro Activity of Oral Antimicrobial Agents against Pathogens Associated with Community-Acquired Upper Respiratory Tract and Urinary Tract Infections: A Five Country Surveillance Study Biedenbach, Douglas J.
2016
3 p. 405
artikel
86 Erratum to: Single-Dose Oritavancin Treatment of Acute Bacterial Skin and Skin Structure Infections: SOLO Trial Efficacy by Eron Severity and Management Setting Deck, Daniel H.
2016
3 p. 363-365
artikel
87 Estimated Respiratory Syncytial Virus-Related Hospitalizations and Deaths Among Children and Adults in Spain, 2016–2019 Haeberer, Mariana

3 p. 463-480
artikel
88 Estimates of the Health and Economic Burden of Pneumococcal Infections Attributable to the 15-Valent Pneumococcal Conjugate Vaccine Serotypes in the USA Owusu-Edusei, Kwame

3 p. 987-999
artikel
89 Evaluating the Follow-up of Post-discharge Positive Sterile Site Cultures and the Impact on Infection-Related Complications LaPlante, Reid

3 p. 989-996
artikel
90 Evaluation of Pharmacodynamic Interactions Between Telavancin and Aztreonam or Piperacillin/Tazobactam Against Pseudomonas aeruginosa, Escherichia coli and Methicillin-Resistant Staphylococcus aureus Yim, Juwon
2016
3 p. 367-377
artikel
91 Evaluation of Plazomicin, Tigecycline, and Meropenem Pharmacodynamic Exposure against Carbapenem-Resistant Enterobacteriaceae in Patients with Bloodstream Infection or Hospital-Acquired/Ventilator-Associated Pneumonia from the CARE Study (ACHN-490-007) Kuti, Joseph L.
2019
3 p. 383-396
artikel
92 Evaluation of the Dynamiker® Fungus (1–3)-β-d-Glucan Assay for the Diagnosis of Invasive Aspergillosis in High-Risk Patients with Hematologic Malignancies Siopi, Maria

3 p. 1161-1175
artikel
93 Expanding Antimicrobial Stewardship to Urgent Care Centers Through a Pharmacist-Led Culture Follow-up Program Dumkow, Lisa E.
2017
3 p. 453-459
artikel
94 Exploring the Clinical Utility of Metagenomic Next-Generation Sequencing in the Diagnosis of Pulmonary Infection Xie, Guijuan

3 p. 1419-1435
artikel
95 Fournier’s Gangrene with Growth of Actinomyces europaeus: A Case Report Zhang, Shurong

3 p. 1007-1011
artikel
96 Guideline Recommendations for Empirical Antimicrobial Therapy: An Appraisal of Research Evidence for Clinical Decision-Making in Ethiopia Arega, Balew

3 p. 451-465
artikel
97 Healthcare Resource Consumption and Cost of Invasive Meningococcal Disease in France: A Study of the National Health Insurance Database Weil-Olivier, Catherine

3 p. 1607-1623
artikel
98 Hepatitis C Therapy in Renal Patients: Who, How, When? Isnard Bagnis, Corinne
2016
3 p. 313-327
artikel
99 High Frequency of Polymicrobial Infections After Surgical Resection of Malignant Bone and Soft Tissue Tumors: A Retrospective Cohort Study Vos, Laura M.
2015
3 p. 307-319
artikel
100 HIV-1 Virologic Rebound Due to Coadministration of Divalent Cations and Bictegravir Rock, Alex E.

3 p. 691-696
artikel
101 Immunogenicity of a Quadrivalent Human Papillomavirus Vaccine When Co-Administered with Tetanus-Reduced Diphtheria-Acellular Pertussis and Quadrivalent Meningococcal Conjugate Vaccines in Healthy Adolescents: Results from a Randomized, Observer-Blind, Controlled Trial Miao, Yan
2019
3 p. 335-341
artikel
102 Impact of Inflammatory Response Modifiers on the Incidence of Hospital-Acquired Infections in Patients with COVID-19 Meira, Fernanda

3 p. 1407-1418
artikel
103 Impact of Sexualized Substance Use and Other Risk Practices on HCV Microelimination in gbMSM Living with HIV: Urgent Need for Targeted Strategies. Results of a Retrospective Cohort Study Martínez-Rebollar, María

3 p. 1253-1266
artikel
104 Impact of Valve Culture Positivity on Prognosis in Patients with Infective Endocarditis Who Underwent Valve Surgery Kim, Jinnam

3 p. 1253-1265
artikel
105 Improvement of Hepatic and Extrahepatic Complications from Chronic Hepatitis C After Antiviral Treatment: A Retrospective Analysis of German Sickness Fund Data Kraus, Michael R.
2018
3 p. 339-352
artikel
106 Incidence of and Risk Factors for Acute Kidney Injury During Antituberculosis Treatment: A Prospective Cohort Study and Literature Review Chang, Chia-Hao

3 p. 919-931
artikel
107 In Search of the SARS-CoV-2 Protection Correlate: Head-to-Head Comparison of Two Quantitative S1 Assays in Pre-characterized Oligo-/Asymptomatic Patients Rubio-Acero, Raquel

3 p. 1505-1518
artikel
108 Interferon Treatments for SARS-CoV-2: Challenges and Opportunities Jhuti, Diya

3 p. 953-972
artikel
109 Interpretable Machine Learning for Early Prediction of Prognosis in Sepsis: A Discovery and Validation Study Hu, Chang

3 p. 1117-1132
artikel
110 In vitro and In vivo Activity of Theaflavin–Epicatechin Combinations versus Multidrug-Resistant Acinetobacter baumannii Betts, Jonathan W.
2017
3 p. 435-442
artikel
111 β-Lactam Resistance in ESKAPE Pathogens Mediated Through Modifications in Penicillin-Binding Proteins: An Overview Sethuvel, Dhiviya Prabaa Muthuirulandi

3 p. 829-841
artikel
112 Late cART Initiation Consistently Driven by Late HIV Presentation: A Multicenter Retrospective Cohort Study in Taiwan from 2009 to 2019 Lee, Chun-Yuan

3 p. 1033-1056
artikel
113 Legionnaires’ Disease: Update on Diagnosis and Treatment Viasus, Diego

3 p. 973-986
artikel
114 Letter to the Editor Regarding Combination of Tocilizumab and Steroids to Improve Mortality in Patients with Severe COVID-19 Infection: A Spanish, Multicenter, Cohort Study Janapala, Rajesh Naidu

3 p. 1807-1809
artikel
115 Living During COVID-19 While Immunocompromised: A Patient and Physician Perspective from France Foudrat, Elise

3 p. 439-445
artikel
116 Long-Term Patient-Centred Follow-up in a Prospective Cohort of Patients with COVID-19 Righi, Elda

3 p. 1579-1590
artikel
117 Long-Term Serological Response to 13-Valent Pneumococcal Conjugate Vaccine Versus 23-Valent Polysaccharide Vaccine in HIV-Infected Adults Belmonti, Simone
2019
3 p. 453-462
artikel
118 Maraviroc Intensification Improves Endothelial Function in Abacavir-Treated Patients, an Open-Label Randomized Cross-Over Pilot Study Krikke, Maaike
2016
3 p. 389-404
artikel
119 MenB-FHbp Vaccine Protects Against Diverse Meningococcal Strains in Adolescents and Young Adults: Post Hoc Analysis of Two Phase 3 Studies Beeslaar, Johannes

3 p. 641-656
artikel
120 Meta-Analysis of Efficacy and Safety of Coformulated Bictegravir, Emtricitabine, and Tenofovir Alafenamide Among People Living with HIV Chen, I-Wen

3 p. 1331-1346
artikel
121 Metagenomic Next-Generation Sequencing for the Diagnosis of Pneumocystis jirovecii Pneumonia in Non-HIV-Infected Patients: A Retrospective Study Jiang, Juan

3 p. 1733-1745
artikel
122 Molecular Characterization of Invasive Carbapenem-Resistant Acinetobacter baumannii from a Tertiary Care Hospital in South India Vijayakumar, Saranya
2016
3 p. 379-387
artikel
123 Monoclonal Antibodies in Hospitalised Patients with COVID-19: The Role of SARS-COV-2 Serostatus in an Evolving Pandemic Raffi, François

3 p. 735-747
artikel
124 New Antiretroviral Treatment for HIV Badowski, Melissa E.
2016
3 p. 329-352
artikel
125 Novel Naturally Occurring Dipeptides and Single-Stranded Oligonucleotide Act as Entry Inhibitors and Exhibit a Strong Synergistic Anti-HIV-1 Profile Ceña-Diez, Rafael

3 p. 1103-1116
artikel
126 Oritavancin Versus Daptomycin for Osteomyelitis Treatment After Surgical Debridement Van Hise, Nicholas W.

3 p. 535-547
artikel
127 Outcomes for Patients with Urinary Tract Infection After an Initial Intravenous Antibiotics Dose Before Emergency Department Discharge Poh, Xue-Er

3 p. 1479-1489
artikel
128 Outcomes of Drug Interactions Between Antiretrovirals and Co-Medications, Including Over-the-Counter Drugs: A Real-World Study Ambrosioni, Juan

3 p. 609-617
artikel
129 Passive Screening and Diagnosis of Sleeping Sickness with New Tools in Primary Health Services: An Operational Research Mulenga, Philippe
2019
3 p. 353-367
artikel
130 Patients with COVID-19 and HBV Coinfection are at Risk of Poor Prognosis Yang, Shanshan

3 p. 1229-1242
artikel
131 Pertussis in Individuals with Co-morbidities: A Systematic Review Macina, Denis

3 p. 1141-1170
artikel
132 Pharmacists’ Knowledge About the Impact of Augmented Renal Clearance on Antimicrobial Dosing in Critically Ill Patients: A Cross-Sectional Study Almulhim, Abdulaziz S.

3 p. 599-608
artikel
133 Podcast: Influenza-Associated Complications and the Impact of Vaccination on Public Health Maggi, Stefania

3 p. 413-420
artikel
134 Polymerase Chain Reaction Versus Blood Culture to Detect Candida Species in High-Risk Patients with Suspected Invasive Candidiasis: The MICAFEM Study Nieto, Mercedes
2019
3 p. 429-444
artikel
135 Post-Marketing Surveillance of Adverse Events Following Vaccination with the Live-Attenuated Japanese Encephalitis Chimeric Virus Vaccine (Imojev®) in South Korea, 2015–2019 Kim, Hee Soo

3 p. 589-598
artikel
136 Povidone-Iodine Demonstrates Rapid In Vitro Virucidal Activity Against SARS-CoV-2, The Virus Causing COVID-19 Disease Anderson, Danielle E.

3 p. 669-675
artikel
137 Predictors of Mortality and Drug Resistance Among Carbapenem-Resistant Enterobacteriaceae-Infected Pancreatic Necrosis Patients Wu, Di

3 p. 1665-1676
artikel
138 Prevalence and Mortality due to COVID-19 in HIV Co-Infected Population: A Systematic Review and Meta-Analysis Liang, Min

3 p. 1267-1285
artikel
139 Prevalence of Mycobacterium tuberculosis (Rifampicin-Resistant MTB) and Associated Risk Actors Among Pulmonary Presumptive TB Patients in Eastern Amhara, Ethiopia: 2015–2019 Wasihun, Araya Gebreyesus

3 p. 1299-1308
artikel
140 Prognostic Role of Soluble Urokinase Plasminogen Activator Receptor at the Emergency Department: A Position Paper by the Hellenic Sepsis Study Group Velissaris, Dimitrios

3 p. 407-416
artikel
141 Prognostic Value of Serum Ferritin for Patients with Severe Fever with Thrombocytopenia Syndrome: A Single-Center Retrospective Cohort Study Xie, Jiao

3 p. 979-988
artikel
142 Publisher Correction: Podcast: Influenza-Associated Complications and the Impact of Vaccination on Public Health Maggi, Stefania

3 p. 421
artikel
143 Pulmonary Aspergillosis: An Evolving Challenge for Diagnosis and Treatment Russo, Alessandro

3 p. 511-524
artikel
144 Pursuing Elimination of Hepatitis C in Egypt: Cost-Effectiveness and Economic Evaluation of a Country-Wide Program Schwander, Bjoern

3 p. 1193-1203
artikel
145 Randomized Prospective Open Label Study Shows No Impact on Clinical Outcome of Adding Losartan to Hospitalized COVID-19 Patients with Mild Hypoxemia Geriak, Matthew

3 p. 1323-1330
artikel
146 Rationale for the Development of a Pentavalent Meningococcal Vaccine: A US-Focused Review Marshall, Gary S.

3 p. 937-951
artikel
147 Real-Life Evidence for Tedizolid Phosphate in the Treatment of Cellulitis and Wound Infections: A Case Series Shlyapnikov, Sergey
2018
3 p. 387-399
artikel
148 Real-World Treatment of Complicated Skin and Soft Tissue Infections with Daptomycin: Results from a Large European Registry (EU-CORE) Cogo, Alberto
2015
3 p. 273-282
artikel
149 Real-World Treatment of Enterococcal Infections with Daptomycin: Insights from a Large European Registry (EU-CORE) Lübbert, Christoph
2015
3 p. 259-271
artikel
150 Reanalysis of the Clinical and Economic Burden of Pneumococcal Disease Due to Serotypes Contained in Current and Investigational Pneumococcal Conjugate Vaccines in Children < 5 Age: A Societal Perspective Li, Xiuyan

3 p. 997-1006
artikel
151 Reduction in Sporadic Norovirus Infections Following the Start of the COVID-19 Pandemic, 2019–2020, Philadelphia Nachamkin, Irving

3 p. 1793-1798
artikel
152 Refining “Long-COVID” by a Prospective Multimodal Evaluation of Patients with Long-Term Symptoms Attributed to SARS-CoV-2 Infection Scherlinger, Marc

3 p. 1747-1763
artikel
153 Risk Factors Associated with Linkage to Care among Suburban Hepatitis C-Positive Baby Boomers and Injection Drug Users Lier, Audun J.
2019
3 p. 417-428
artikel
154 Risk Factors for Melioidosis Mortality and Epidemics: A Multicentre, 10-Year Retrospective Cohort Study in Northern Hainan Zheng, Wanting

3 p. 951-964
artikel
155 Risk Factors for Mortality Among Critical Acute Pancreatitis Patients with Carbapenem-Resistant Organism Infections and Drug Resistance of Causative Pathogens Wu, Di

3 p. 1089-1101
artikel
156 Safety, Efficacy and Pharmacokinetics of AZD7442 (Tixagevimab/Cilgavimab) for Treatment of Mild-to-Moderate COVID-19: 15-Month Final Analysis of the TACKLE Trial Hobbs, F. D. Richard

3 p. 521-533
artikel
157 Screening for Cryptococcal Antigenemia and Burden of Cryptococcosis at the Time of HIV Diagnosis: A Retrospective Multicenter Study Huang, Sung-Hsi

3 p. 1363-1377
artikel
158 Sex, Age, and Race Effects on Immunogenicity of MenB-FHbp, A Bivalent Meningococcal B Vaccine: Pooled Evaluation of Clinical Trial Data Beeslaar, Johannes

3 p. 625-639
artikel
159 Short-Course Versus Long-Course Systemic Antibiotic Treatment for Uncomplicated Intravascular Catheter-Related Bloodstream Infections due to Gram-Negative Bacteria, Enterococci or Coagulase-Negative Staphylococci: A Systematic Review Muff, Severin

3 p. 1591-1605
artikel
160 Shorter Time to Discontinuation Due to Treatment Failure in People Living with HIV Switched to Dolutegravir Plus Either Rilpivirine or Lamivudine Compared with Integrase Inhibitor-Based Triple Therapy in a Large Spanish Cohort Teira, Ramón

3 p. 1177-1192
artikel
161 Single-Dose Oritavancin Treatment of Acute Bacterial Skin and Skin Structure Infections: SOLO Trial Efficacy by Eron Severity and Management Setting Deck, Daniel H.
2016
3 p. 353-361
artikel
162 Surgical Treatment of Persistent Pseudomonas aeruginosa Bacteraemia After n-Butyl-2-cyanoacrylate for Gastric Bleeding Varices Sempere, Abiu

3 p. 619-624
artikel
163 Systematic Literature Review of Real-world Evidence of Ceftolozane/Tazobactam for the Treatment of Respiratory Infections Puzniak, Laura

3 p. 1227-1252
artikel
164 Systematic Review and Subgroup Meta-analysis of Randomized Trials to Determine Tocilizumab’s Place in COVID-19 Pneumonia Klopfenstein, Timothée

3 p. 1195-1213
artikel
165 Systematic Review on the Correlation Between SARS-CoV-2 Real-Time PCR Cycle Threshold Values and Epidemiological Trends Sala, Ester

3 p. 749-775
artikel
166 Systemic Antifungal Prophylaxis in Patients Hospitalized in Hematology Units in France: The AFHEM Cross-Sectional Observational Study Gangneux, Jean-Pierre
2018
3 p. 309-325
artikel
167 Targeted Literature Review of the Burden of Respiratory Syncytial Infection among High-Risk and Elderly Patients in Asia Pacific Region Kurai, Daisuke

3 p. 807-828
artikel
168 Telavancin in Hospital-Acquired and Ventilator-Associated Pneumonia (HAP/VAP) Caused by Staphylococcus aureus: Post Hoc Analysis of 2 Randomized, Controlled Trials Niederman, Michael S.
2019
3 p. 445-452
artikel
169 Telavancin in the Treatment of Concurrent Staphylococcus aureus Bacteremia: A Retrospective Analysis of ATLAS and ATTAIN Studies Wilson, Samuel E.
2017
3 p. 413-422
artikel
170 That Escalated Quickly: Remdesivir's Place in Therapy for COVID-19 Davis, Matthew R.

3 p. 525-536
artikel
171 The Comparative Influence of 2 and 4 Weeks Preoperative Antituberculosis Treatment on Spinal Tuberculosis Surgery: A Multicenter, Prospective, Randomized Clinical Trial Fan, Jun

3 p. 1451-1463
artikel
172 The Global Trends and Regional Differences in Incidence of Dengue Infection from 1990 to 2019: An Analysis from the Global Burden of Disease Study 2019 Du, Min

3 p. 1625-1643
artikel
173 The Impact of Hepatitis C Virus Direct-Acting Antivirals on Patient-Reported Outcomes: A Dutch Prospective Cohort Study Kracht, Patricia A. M.
2018
3 p. 373-385
artikel
174 The Impact of the COVID-19 Pandemic on the Incidence of Herpes Zoster: A Narrative Literature Review Parikh, Raunak

3 p. 447-461
artikel
175 The Influence of Patient Experience with Healthcare on the Health-Related Quality of Life of People Living with HIV: An Observational Cross-Sectional Survey Fuster-RuizdeApodaca, María J.
2019
3 p. 369-382
artikel
176 The Pharmacokinetic and Pharmacodynamic Properties of Hydroxychloroquine and Dose Selection for COVID-19: Putting the Cart Before the Horse Morrisette, Taylor

3 p. 561-572
artikel
177 The Role of Macrolides for the Management of Community-Acquired Pneumonia and Pneumonia by the Novel Coronavirus SARS-CoV-2 (COVID-19): A Position Paper by Four Medical Societies from Greece Giamarellos-Bourboulis, Evangelos J.

3 p. 1081-1095
artikel
178 The Role of Metabolic Factors and Steatosis in Treatment-Naïve Patients with Chronic Hepatitis B and Normal Alanine Aminotransferase Diao, Yuting

3 p. 1133-1148
artikel
179 The Use and Effectiveness of Ceftazidime–Avibactam in Real-World Clinical Practice: EZTEAM Study Soriano, Alex

3 p. 891-917
artikel
180 Transient Elastography for the Detection of Liver Damage in Patients with HIV Sagir, Abdurrahman
2015
3 p. 355-364
artikel
181 Treatment Discontinuation, Adherence, and Real-World Effectiveness Among Patients Treated with Ledipasvir/Sofosbuvir in the United States Puenpatom, Amy
2017
3 p. 423-433
artikel
182 Treatment of Ruptured Infected Abdominal Aortic Aneurysm Caused by Salmonella spp.: A Case Report Napiórkowska-Baran, Katarzyna

3 p. 1799-1805
artikel
183 Treatments Administered to the First 9152 Reported Cases of COVID-19: A Systematic Review Fajgenbaum, David C.

3 p. 435-449
artikel
184 Vaccinations for the HIV-Infected Adult: A Review of the Current Recommendations, Part I Crum-Cianflone, Nancy F.
2017
3 p. 303-331
artikel
185 Vaccinations for the HIV-Infected Adult: A Review of the Current Recommendations, Part II Crum-Cianflone, Nancy F.
2017
3 p. 333-361
artikel
186 Vaccine Hesitancy as a Challenge or Vaccine Confidence as an Opportunity for Childhood Immunisation in India Agrawal, Ashish

3 p. 421-432
artikel
187 Validation of a Novel Forecasting Method for Estimating the Impact of Switching Pneumococcal Conjugate Programs: Evidence from Belgium Wilson, Michele R.

3 p. 1765-1778
artikel
188 Viral Respiratory Infections in Hematological Patients Gabutti, Giovanni

3 p. 495-510
artikel
                             188 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland